Characteristics of a novel phospholipid-based depot injectable technology for poorly water-soluble drugs.
Tiemessen
Harry
H
Phares Drug Delivery AG, Muttenz, Switzerland.
van Hoogevest
Peter
P
Leigh
Mathew L S
ML
D000284:Administration, Oral; D000818:Animals; D002417:Cattle; D002626:Chemistry, Pharmaceutical; D003692:Delayed-Action Preparations / Q000008:administration & dosage / Q000737:chemistry / Q000378:metabolism; D007279:Injections, Subcutaneous; D008297:Male; D004364:Pharmaceutical Preparations / Q000008:administration & dosage* / Q000737:chemistry / Q000378:metabolism; D010743:Phospholipids / Q000008:administration & dosage* / Q000097:blood / Q000737:chemistry; D012995:Solubility / Q000187:drug effects; D014867:Water / Q000008:administration & dosage* / Q000737:chemistry / Q000378:metabolism
D003692:Delayed-Action Preparations; D004364:Pharmaceutical Preparations; D010743:Phospholipids; D014867:Water